Literature DB >> 30815826

Emerging Role of the Pathologist in Precision Medicine for HCC.

Thomas Longerich1, Peter Schirmacher2.   

Abstract

Mesh：

Year:  2019        PMID： 30815826     DOI： 10.1007/s10620-019-05548-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  45 in total

1.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

2.  Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.

Authors:  Elad Horwitz; Ilan Stein; Mariacarla Andreozzi; Julia Nemeth; Avivit Shoham; Orit Pappo; Nora Schweitzer; Luigi Tornillo; Naama Kanarek; Luca Quagliata; Farid Zreik; Rinnat M Porat; Rutie Finkelstein; Hendrik Reuter; Ronald Koschny; Tom Ganten; Carolin Mogler; Oren Shibolet; Jochen Hess; Kai Breuhahn; Myriam Grunewald; Peter Schirmacher; Arndt Vogel; Luigi Terracciano; Peter Angel; Yinon Ben-Neriah; Eli Pikarsky
Journal:  Cancer Discov       Date:  2014-03-31       Impact factor: 39.397

Review 3.  Is tumor biopsy necessary?

Authors:  Beat Müllhaupt; Francois Durand; Tanja Roskams; Philipp Dutkowski; Markus Heim
Journal:  Liver Transpl       Date:  2011-10       Impact factor: 5.799

Review 4.  Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians.

Authors:  Michael Allgäuer; Jan Budczies; Petros Christopoulos; Volker Endris; Amelie Lier; Eugen Rempel; Anna-Lena Volckmar; Martina Kirchner; Moritz von Winterfeld; Jonas Leichsenring; Olaf Neumann; Stefan Fröhling; Roland Penzel; Michael Thomas; Peter Schirmacher; Albrecht Stenzinger
Journal:  Transl Lung Cancer Res       Date:  2018-12

5.  Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Carol E A Peña; Chetan D Lathia; Michael Shan; Gerold Meinhardt; Jordi Bruix
Journal:  Clin Cancer Res       Date:  2012-02-28       Impact factor: 12.531

Review 6.  Multiplexed Epitope-Based Tissue Imaging for Discovery and Healthcare Applications.

Authors:  Bernd Bodenmiller
Journal:  Cell Syst       Date:  2016-04-27       Impact factor: 10.304

7.  Gene-expression signature of vascular invasion in hepatocellular carcinoma.

Authors:  Beatriz Mínguez; Yujin Hoshida; Augusto Villanueva; Sara Toffanin; Laia Cabellos; Swan Thung; John Mandeli; Daniela Sia; Craig April; Jian-Bing Fan; Anja Lachenmayer; Radoslav Savic; Sasan Roayaie; Vincenzo Mazzaferro; Jordi Bruix; Myron Schwartz; Scott L Friedman; Josep M Llovet
Journal:  J Hepatol       Date:  2011-04-13       Impact factor: 25.083

Review 8.  Hepatocellular adenoma: Classification, variants and clinical relevance.

Authors:  Paulette Bioulac-Sage; Christine Sempoux; Charles Balabaud
Journal:  Semin Diagn Pathol       Date:  2016-12-20       Impact factor: 3.464

9.  A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.

Authors:  Jean-Charles Nault; Aurélien De Reyniès; Augusto Villanueva; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Thomas Decaens; Dominique Franco; Sandrine Imbeaud; Francis Rousseau; Daniel Azoulay; Jean Saric; Jean-Frédéric Blanc; Charles Balabaud; Paulette Bioulac-Sage; Alexis Laurent; Pierre Laurent-Puig; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2013-04-06       Impact factor: 22.682

10.  Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.

Authors: 
Journal:  Cell       Date:  2017-06-15       Impact factor: 66.850
View more
  1 in total

Review 1.  [Pathology of liver tumors].

Authors:  P Schirmacher
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.